'World changer': Ghana first to approve Oxford malaria vaccine with 77 percent
The R21/Matrix-M vaccine has been approved for use in children aged five to 36 months, the group at the highest risk of death from malaria.
Burkina Faso Adrian Hill University Of Oxford Jenner Institute Nuffield Department Of Medicine University Of Oxford Jenner Institute
Source: interestingengineering.com